Literature DB >> 33432919

Residual daytime effects of esmirtazapine.

Neely Ivgy-May1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33432919      PMCID： PMC8020688          DOI： 10.5664/jcsm.9120

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  2 in total

1.  Efficacy and safety of esmirtazapine in adult outpatients with chronic primary insomnia: a randomized, double-blind placebo-controlled study and open-label extension.

Authors:  Neely Ivgy-May; Goeran Hajak; Gonnie van Osta; Sabine Braat; Qing Chang; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2020-09-15       Impact factor: 4.062

2.  Efficacy and safety of esmirtazapine in adult insomnia: unsupported statements about residual daytime effects.

Authors:  R Bart Sangal
Journal:  J Clin Sleep Med       Date:  2021-02-01       Impact factor: 4.062
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.